The hangup is that the company is broke and can't afford to do the normal and expected things a biotech has to do to get drugs approved. Mismanagement? Yup!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.